APOE ε2 is linked to impaired remyelination in MS but is protective against Alzheimer's disease (AD) and associates with higher myelin content (Corder et al., 1994; Carlin et al., 2000; Suri et al., 2013). The gene discussed is APOE; the disease is myeloid sarcoma.